SCHEMBL29429746

SCHEMBL29429746

C#CC1(COC(=O)c2ccc(C)cc2)OCC[C@@H]1OC(=O)c1ccc(C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.40
▸ PRKCA P17252 3/20 0.39
▸ PRKCG P05129 1/20 0.39
▸ PRKCB P05771 1/20 0.39
▸ PRKCE Q02156 1/20 0.39
▸ PRKCD Q05655 1/20 0.39
▸ SCN1A P35498 1/20 0.39
▸ SCN2A Q99250 1/20 0.39
▸ SCN3A Q9NY46 1/20 0.39
▸ RAB9A P51151 6/20 0.39
▸ LGALS9 O00182 1/20 0.35
▸ LGALS1 P09382 1/20 0.35
▸ LGALS3 P17931 1/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ TRPV1 Q8NER1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31308611 1.00 POLB (0.40) POLBPRKCAPRKCGPRKCBPRKCE
SCHEMBL18670654 0.81 HPGD (0.38) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL18670642 0.81 PRKCA (0.41) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL18670630 0.81 HPGD (0.38) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL18670644 0.81 PRKCA (0.41) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL18670633 0.81 PRKCA (0.37) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL18670631 0.81 PRKCA (0.37) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL26129664 0.81 PRKCA (0.37) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL26135802 0.81 PRKCA (0.37) PRKCAPRKCGPRKCBPRKCEPRKCD
SCHEMBL18670646 0.80 SCN1A (0.38) POLBPRKCAPRKCGPRKCBPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4216962-A1 LINE-1 INHIBITORS TO TREAT DISEASE Transposon Therapeutics, Inc. (US) 2023-08-02 — — EP disclosed
WO-2022066880-A1 LINE-1 INHIBITORS TO TREAT DISEASE TRANSPOSON THERAPEUTICS, INC. (US) 2022-03-31 — — WO disclosed
Send feedback